Collateralized Loan Obligation (CLO) ETFs are experiencing accelerated growth due to their structural immunity to rising interest rates, a feature that has negatively impacted approximately 85% of traditional bond ETFs. This resilience is positioning CLO products as a preferred fixed-income alternative as rate pressures persist across broader markets.
The primary trade-off involves increased credit risk for underlying borrowers facing higher funding costs. However, the U.S. economy remains relatively firm, supporting asset quality. Funds like JAAA, which hold the highest-quality CLO tranches, continue to demonstrate stability against benchmarks including the 10-year yield and aggregate bond indices.
CLO ETFs Gain Momentum as Rising Rate Immunity Drives Growth Amid Bond Market Stress
免責事項: Phemexニュースで提供されるコンテンツは、あくまで情報提供を目的としたものであり、第三者の記事から取得した情報の正確性・完全性・信頼性について保証するものではありません。本コンテンツは金融または投資の助言を目的としたものではなく、投資に関する最終判断はご自身での調査と、信頼できる専門家への相談を踏まえて行ってください。
